Marek Wrocławski is an experienced finance professional with a strong background in business planning and analysis within the pharmaceutical sector. Currently serving as Associate Director Finance for Biosimilars at Biogen since September 2024, Marek previously held prominent roles at Sandoz, including Senior BPA Manager and Finance Controller BPA from March 2022 to August 2024, focusing on budgeting, forecasting, and pricing analysis for specialty medicines. Prior experiences include positions as Financial Analyst and Senior Financial Analyst at Baxter Polska Sp. z o.o., where responsibilities encompassed monthly reporting, budgeting, and collaboration with various business units. Educational qualifications include a Master’s degree in Informatyka i Ekonometria from Uniwersytet Łódzki and postgraduate studies in MSSF w praktyce (IFRS) at SGH Warsaw School of Economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices